Reactive oxygen species (
ROS
) are emerging as important regulators of cancer growth and metastatic spread. However, how cells integrate redox signals to affect cancer progression is not fully understood. Mitochondria are cellular redox hubs, which are highly regulated by interactions with neighboring organelles. Here, we investigated how
ROS
at the endoplasmic reticulum (
ER
)–mitochondria interface are generated and translated to affect melanoma outcome. We show that
TMX
1 and
TMX
3 oxidoreductases, which promote
ER
–mitochondria communication, are upregulated in melanoma cells and patient samples.
TMX
knockdown altered mitochondrial organization, enhanced bioenergetics, and elevated mitochondrial‐ and
NOX
4‐derived
ROS
. The
TMX
‐knockdown‐induced oxidative stress suppressed melanoma proliferation, migration, and xenograft tumor growth by inhibiting
NFAT
1. Furthermore, we identified
NFAT
1‐positive and
NFAT
1‐negative melanoma subgroups, wherein
NFAT
1 expression correlates with melanoma stage and metastatic potential. Integrative bioinformatics revealed that genes coding for mitochondrial‐ and redox‐related proteins are under
NFAT
1 control and indicated that
TMX
1,
TMX
3, and
NFAT
1 are associated with poor disease outcome. Our study unravels a novel redox‐controlled
ER
–mitochondria–
NFAT
1 signaling loop that regulates melanoma pathobiology and provides biomarkers indicative of aggressive disease.